Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Alcohols,Phenols,Phenol alcohols >  (2-bromo-5H-pyrrolo[2,3-b]pyrazin-7-yl)methanol

(2-bromo-5H-pyrrolo[2,3-b]pyrazin-7-yl)methanol

Basic information Safety Supplier Related

(2-bromo-5H-pyrrolo[2,3-b]pyrazin-7-yl)methanol Basic information

Product Name:
(2-bromo-5H-pyrrolo[2,3-b]pyrazin-7-yl)methanol
Synonyms:
  • (2-bromo-5H-pyrrolo[2,3-b]pyrazin-7-yl)methanol
  • 5H-Pyrrolo[2,3-b]pyrazine-7-methanol, 2-bromo-
CAS:
1334674-88-2
MF:
C7H6BrN3O
MW:
228.05
Mol File:
1334674-88-2.mol
More
Less

(2-bromo-5H-pyrrolo[2,3-b]pyrazin-7-yl)methanol Chemical Properties

storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
More
Less

(2-bromo-5H-pyrrolo[2,3-b]pyrazin-7-yl)methanol Usage And Synthesis

Synthesis

1334674-87-1

1334674-88-2

Step 2. Synthesis of (2-bromo-5H-pyrrolo[2,3-b]pyrazin-7-yl)methanol. An aqueous solution of sodium hydroxide (NaOH, 70.3 g, 1.758 mol) (880 mL) was added slowly and dropwise to an aqueous solution of (2-bromo-5H-pyrrolo[2,3-b]pyrazin-5,7-diyl)dimethanol (150 g, 586 mmol) in tetrahydrofuran (THF, 1.5 L) suspension. After the dropwise addition, the reaction mixture was stirred for 18 h at room temperature. The reaction progress was monitored by hydrogen nuclear magnetic resonance (HNMR), which showed about 18% of the feedstock remaining. The reaction mixture was continued to be stirred at room temperature for 48 hours until HNMR confirmed complete consumption of the feedstock. Three batches of the reaction mixture were combined for post-processing. First, most of the THF was removed by rotary evaporation.Subsequently, the aqueous phase residue was acidified to pH = 3-4 with 2 M hydrochloric acid (HCl) and extracted with ethyl acetate (EtOAc, 3 × 3 L). The organic layers were combined, washed sequentially with water (3 L) and saturated brine (3 L), dried over anhydrous sodium sulfate (Na2SO4), and concentrated to afford (2-bromo-5H-pyrrolo[2,3-b]pyrazin-7-yl)methanol (381 g, 96% yield) as a yellow solid, which could be used in the subsequent steps without further purification.

References

[1] Patent: US2015/158864, 2015, A1. Location in patent: Paragraph 0649
[2] Patent: US2011/230462, 2011, A1. Location in patent: Page/Page column 54; 56
[3] Patent: WO2011/144584, 2011, A1. Location in patent: Page/Page column 36
[4] Patent: WO2011/144585, 2011, A1. Location in patent: Page/Page column 98
[5] Journal of Medicinal Chemistry, 2013, vol. 56, # 1, p. 345 - 356

(2-bromo-5H-pyrrolo[2,3-b]pyrazin-7-yl)methanolSupplier

BePharm Ltd
Tel
400-685-9117
Email
market@bepharm.com
NINGBOBENKANGJS PHARMTECHCO., LTD
Tel
+8615990591583 15990591583
Ningbo Benkang jishi Pharmaceutical Technology Co., Ltd.
Tel
15990591583
Shanghai Haohong Pharmaceutical Co., Ltd.
Tel
400-8210725 4008210725
Email
malulu@leyan.com
Zhenjiang Borun Bio-Technology Pharmaceutical Co., Ltd.
Tel
15862994627
Email
2570984291@qq.com